Good morning, everyone, welcome to our second quarterly earnings call 2021. As usual, we will start presenting the quarter and then we'll end up this session with a Q&A moment, and we'll end within the hour, I hope. Without further ado, Per, please go ahead. Thank you, Frans, a really warm welcome to all of you on this second quarter review for ICA Gruppen. If we, as usual, start with a brief summary. This is yet another solid quarter from ICA Gruppen, with stable margins. In this quarter, we have a very strong performance for Rimi Baltic, we also see a nice rebound for our pharmacy business, Apotek Hjärtat. For ICA Sweden, it's a stable quarter, of course, affected by the heavy online investments that we are doing. If we look a little bit at the numbers, starting with net sales, we see a more moderate net sales growth of 1.5% or 2.1% in local currency. This is, of course, impacted by the Easter calendar effect, roughly minus 0.8%, and of course, also by the deflation. I'll come back to the deflation numbers that we have seen here in the second quarter. On the EBIT side, the EBIT is basically flat or -0.4%. I think it's also interesting to compare a little bit to 2019, so before COVID times. If you look at net sales for this two-year period, we are up 6.5%, and on EBIT, we are up 5%. We have also, during the quarter, announced a few key events. First of all, we had the AGM in April where we decided on the dividend of SEK 13 per share, and Charlotte Svensson was also elected new board member for ICA Gruppen. A little bit later in the quarter, in June, we announced our new e-commerce warehouse that we will have in Norrköping for our pharmacy business, which will give us better efficiency over time, that we can continue expansion, and most importantly, build a true omni-channel offering. Moving a little bit to the market development and starting with ICA Sweden. The net sales number, or the store sales numbers, I should say, for ICA Sweden was quite low here in the second quarter, +0.1%, which was also a little bit below market growth of 0.6%. On the other hand, if we look at our comparable store growth of -0.3%, we believe very much that that is in line with the general market development. Here you also see the negative or the deflation that I talked about. We had a negative price effect of -0.6%, which is actually the first negative number that we report since the launch of ICA Gruppen. We're going to come back to what we believe regarding the inflation going forward. On the online side, we saw a growth of 23.5%, so a little bit more moderate growth than we have seen in previous quarters. A little bit of the normalization that we now see come into play. Here we were also slightly below market growth. I wanted to elaborate a little bit on our sales development and our market shares development, and it's really two factors that I wanted to underline. First of all, online. As you know, we have a relatively lower market share online. As this is still, in the second quarter here, a fast-growing market, that means, of course, from an overall perspective, that we lose a little bit of market share. It is also important to remember that we or the ICA stores had an incredible scale-up of capacity in the second quarter of last year. Actually, our growth numbers were really extraordinary there in the second quarter, where we grew 30- 40 percentage points faster than the general market. We are really meeting high growth numbers here. Then I think it is also important to point out that we now see more and more of a normalization of the market, meaning that many customers are returning to stores, and especially people 65 plus that are now double vaccinated. We now see that their share of e-commerce sales has gone from 50% during COVID times down to now 30% of our sales. Quite a large change here. That is the first factor. The second factor is the fact that during the beginning of this year, we have established relatively few new stores. We have added little new sales area compared to competitors. This will change going forward, but it is a fact here for the first half of 2021. Given this, I think it is important to really underline the fact that we are very confident on our strategy going forward. We will continue to push for price value, and especially then with a strong focus on our private label offer that we will develop further and that we will focus even more on. We will continue to leverage the ICA idea and the strength of the ICA system. A vital part of that is strengthening our support to the stores, given the large changes that are coming up, especially on the online side. It's also important for us to focus even more on new establishments and of course, very importantly, store renewals. We will, as you all know, focus on online and on omni-channel. I will come back to that in a little bit more detail later on. We really want to differentiate to be best in class when it comes to health and sustainability, and I will give you a little bit more details on that in a minute as well. Then, of course, loyalty is key to success, and we're going to continue to work with personalization and by that, increasing loyalty. All in all, the strategy remains the same, and we are confident on our strategy. I also wanted to share with you the July numbers. When we look at the second quarter, you saw that our share performance improved a little bit in June relative to April and May. This was further reinforced in July. If we look at the July numbers, ICA store sales were up 3.6% versus the market growing 1.2%. Here it's of course important to remember that in the beginning of July, we had the Coop IT incident, and we estimate that that means that our sales increased from that effect with roughly one percentage point. So if you look at an underlying basis, without this Coop effect, we estimate our sales growth to be around 2.6%. That is still a very strong number versus the general market, and it's mainly driven by our smaller store formats. We had a very strong summer for ICA Nära and of course partly driven by a normalization but of course also good summer weather in Sweden. This means that if we now look at the numbers year to date July, we are basically, as you can see, growing in line with the market 1.6% versus 1.7%. If we look at stores as well as online, we are performing slightly better than the general market. A strong July, no doubt about that. If we move on to Rimi Baltic. We have had a very good quarter for Rimi Baltic, especially so from a sales perspective, and we see a strong recovery with Rimi store sales up 12% in the quarter, so an extraordinarily strong number. Especially if you compare it to the general market growth around 6%, it's really a compelling number. We also see online sales increasing by 134%, meaning that our share online is now above 2% or 2.3%. This actually means that we are gaining market share also in all of the three Baltic countries during the quarter. Also on the pharmacy side, we saw a very strong sales rebound. You all remember that the first quarter of this year was very challenging from a market perspective. Now we are moving into more normal consumption habits. We saw store sales growing or pharmacy sales growing by 7.6%. Good number. Also here, we are gaining market share, market growth being at 7%. This is also true when it comes to online, where we are growing faster than the market at 21% growth. The share online here is at a higher level and now has passed 10% for our pharmacy business. I also wanted to move on to some highlights and starting with online, where we are now in the midst of a very intense transformation phase. There are three things that I'd like to highlight. First of all, the fact that we have now started our e-commerce warehouse in Göteborg, and by year-end, we will have some 20 stores joining this e-commerce warehouse or being serviced by this e-commerce warehouse. So far, we see good quality in picking and delivery. We're off to a good start. We have the change of platform, where we now have started the move to this so-called Ocado Smart Platform or the OSP. We have so far some 20 stores using this new customer-facing platform, and by year-end, we estimate some 140 stores to be on this new platform. So far, so good. We have positive feedback from the customers. We see basket size increasing, and we see margin improvement. We're off to a good start, and as you know, this is a minimum viable product that we have launched, and we will further improve it as we move forward. Finally, another important and of course vital step here when it comes to efficiency is our new automated warehouse in Brunna. The building phase is now finished or finalized. We are now testing or starting to test automation, and we will do test picking and test deliveries during the fourth quarter. We will have a full go live in the beginning of next year. Very exciting times when it comes to our online transformation. The second area that I wanted to touch on is another key area for ICA Gruppen. We really want to be ahead of the game when it comes to sustainability and health for a good tomorrow. Here you see the five key areas that we are working with and also the key KPIs. The key area that I want to touch on today is transportation. If you look at 2020 numbers, roughly 50% of our remaining CO2 emissions is within the transportation area. Here we are taking some important steps already 2021. First of all, we are starting to move for biogas. Biogas, you can say, instead of diesel, and already in 2021, this will mean that we can reduce our emissions in this area by 20%. We are also going electric. We will actually, as of next week, as an important part of our partnership here with Volvo Trucks, start with our first electric truck in the Stockholm area. It will actually be operational, so exciting times, and we are then looking forward, of course, to a further rollout in this area. With that, Sven, I hand over to you and some key financials. Thank you, Per. Good morning, everybody. Indeed a few more words on the financials and starting with the overview. As Per said, of course, looking at this quarter from an overall perspective, it looks very stable, very similar to a year ago. Of course, going a bit beneath the surface, you will see a lot of variances from segment to segment. The net sales number, as Per said, this 1.5% net sales growth is of course a relatively low number if we compare to previous quarters, as we are outlining in the report, held back by a negative Easter impact. Per also talked about price deflation. Price effects, of course, very different to what we had in the second quarter of last year. EBIT, overall, very similar to a year ago. Of course, what stands out is the strong performance in the Baltics and in the pharmacy segment. You see also that clearly reflected in these COVID-19 effects that we are still estimating where we estimate now for this quarter a positive impact in aggregate, whereas last year, of course, in the quite early days of the pandemic following the hoarding period, we saw a negative effect in aggregate. On the negative side then offsetting this positive COVID-19 net effect particularly this one-off credit loss provision that we have made linked to the acquisition that we made in the banking business this quarter. It was this acquisition that we finalized now in May, but we communicated it already before Christmas of last year. You see in the table here, EBIT margin, the same as we reported in the second quarter of 2020. In fact, if you go back also to the second quarter of 2019, you will see that we reported 4.5% also in that quarter. Cash flow, our good trend continues. I'm coming back to that a bit later on. Earnings per share, you see quite significantly up compared to last year, and you will of course understand that it's not coming from the EBIT, but there's some improvements in our financial net where we have improved our interest costs. There is also a quite significant tax accounting impact linked to tax accounting in the Baltics. I won't go into further detail on that now, but you can read about it in our report. Looking at the simplified variance analysis that we normally show, you will see quite positive sales volume impact, very much driven of course by the Baltics and by the pharmacy segment. Looking at the margin impact here, we have positive impact also here coming from the Baltics and the pharmacies not only being about volume impact but also about the margin impact. On the other hand, you will of course recall that in ICA Sweden, we had strong margins in the second quarter of last year. This year, we are not up to those levels, so that is sort of pulling down that bar a bit. Store costs overall very similar to last year but we do of course have cost increases here, most notably in the Baltics linked to the store expansion that we are doing there. On the other hand, as we have talked about also in previous quarters, we have fewer store subs compared to a year ago, which means that we have also lower store cost. That is also reflected in lower gross profit. Here, looking at the store costs, it is pulling down that. Included in this bar is also the store profit sharing, and that you can see from the report that it's up quite significantly compared to a year ago. Other costs up by some SEK 40 million. That's mainly advertising and IT. The acquisition effect, which is of course also quite significant, close to SEK 60 million negative, but to a large extent, as we are outlining in the report, linked to this sort of first-day credit provision that we have taken and that we need to do according to the IFRS 9 accounting regulations. Going to the segments and starting with ICA Sweden. Net sales in absolute terms are very similar to last year. Growth held back by the Easter impact. A bit less positive COVID-19 effect the way we see it, and of course the price deflation. Very different price effects compared to a year ago. Looking at EBIT, we can see on the positive side, of course, then the higher profit sharing. We also would like to say we see a very strong non-food business if we compare to a year ago. On the other hand then, the negative price effects. Easter effect compared to last year due to the different timing of Easter between the years. We estimate minus SEK 20 million in this quarter. You may recall also from last year that we reported a kind of one-off insurance compensation element of some SEK 20 million at that time, which we don't have this year. Also, the COVID-19 effects in aggregate. The elements of the COVID-19 effects are different, but in aggregate they are less positive than a year ago. Then as Per also said at the start, we are of course continuing our investments in scaling up our online operations. We have talked about that in previous quarters, and we also talked about the effect of that when we had the Capital Markets Day in December of last year. That means looking at the table on the right-hand side, that the EBIT margin is somewhat lower than what we reported in Q2 2020. Of course, that was a very high level, and if we compare to the second quarter of 2019, you will see in fact that in that quarter, we were also at this 4.3% level that we have been in this quarter. If we then go to the Baltics, and Per already said it, a very strong quarter, both in terms of net sales growth but also market share growth, and very clearly reflected also in the earnings performance driven by very good volume development. Not only that, we see also very good product mix as we are now coming out of the restriction period sort of gradually during the second quarter. We have seen that we have been in a very good position concerning non-food sales. Also the ready-made meals, which make an important contribution to our earnings, which is very low, if at all existent in the second quarter of last year, has now really come back big time during the second quarter. Giving good mix impacts to our earnings in this quarter. We are still, as I said, continue to invest in the store network, so our store costs are up. We are also in the Baltics continuing to invest in scaling up our e-commerce operations, and we have also invested more in marketing this quarter if we compare to a year ago. Still, of course, the numbers, they talk for themselves. You see in the right-hand side here the very strong improvement, both in absolute terms and in margin terms. Of course, also very happy looking at the pharmacy segment, as Per said, following a first quarter, which was very challenging. Even if at that time we also said that it was particularly January and February which were challenging months. We saw some improvement in March, of course, as things have gradually normalized during the second quarter, we have come back big time in the pharmacy segment. Looked very good in terms of net sales growth as well as market share growth, of course, with this very strong improvement in terms of earnings coming from improved volumes but also from improved efficiency. As you may recall, we talked about when we presented the first quarter results, we are working very much with improving our efficiency, generating additional cost savings and so on. We have a program for that. That is also paying off, obviously. Also here, we are continuing to invest in scaling up the e-commerce operations, digitalization, IT investments and so on. Still, of course, a very welcome rebound also in the EBIT margin, as you can see on the right-hand side here. The real estate segment, that is much more stable if we compare to the other segments. We are growing our income in line with the investments that we have made, and that means also our earnings are improving. We see slightly higher costs in this quarter. Of course, some fluctuations from quarter to quarter. Still, I would say a nice improvement in terms of EBIT also in the real estate segment. Looking at the bank, here it is more complex as we now have this acquisition in the second quarter. We have tried to be as transparent as possible in the report about these effects. There is, of course, an effect on additional net income and also very clearly, as you can see in the numbers, a big impact on our earnings. If we try to look at the bank and insurance business, excluding the acquisition effect, I would say the volume growth in the insurance business is continuing. We see margins improving on certain products in the bank. For the rest, we still have to say volume-wise in this underlying banking business, it has still been a challenging quarter, just like the previous quarter. Much more challenging in some of those income streams linked to our commission income and so on. Of course, again, looking at the EBIT table, seeing that the total acquisition impact is some SEK 60 million, that explains the large part of the variance here. You could say there is then some additional income. There are also some integration costs. There are also, of course, some credit losses linked to the acquired portfolio. Above all, we need to do this first-day credit provision according to accounting rules, and that also is by accident a similar number that's also some SEK 60 million, that item. You could say that explains the largest part of the variance here. Cash flow, as I said, the good trend continues. We see when we close the second quarter, we had quite favorable accounts payable positions linked to the quite late timing of the Midsummer weekend. That is benefiting the cash flow a bit in this quarter, but still the trend is strong. You will also see from the report, obviously, that their capital expenditure is significantly lower compared to a year ago. That we have also talked about previous quarters and in the Capital Markets Day of last year. The way we see it now, those CapEx spend is very much in line with our expectations. Net debt, that is slightly up. We do have a strong cash flow, of course, but here you need to recall that the dividend payments were different. Last year, we split the dividend payment up in two, one half of it in spring and half of it in autumn, whereas this year, we paid all of it in the second quarter. That, of course, temporarily has an impact on the indebtedness level. We mentioned also the report that we made a capital injection to the bank for the acquisition that we made. That also has an impact here, but overall is still relatively stable. Finally, looking at where we are compared to the long-term targets in terms of growing faster than the market. Per talked about Sweden, where we had a bit weaker performance than in the second quarter. On the other hand, we're coming back towards the end of the quarter, and clearly also in July, which is of course not reflected in these numbers. The Baltics and the pharmacy, on the other hand, had very strong second quarter numbers, even if on a rolling 12-month basis, we are not yet quite there to grow faster than the market, but we are getting there. EBIT still with this stable EBIT margin. We're still on a rolling 12-month basis, slightly above the long-term financial target. For the rest on return on capital employed, indebtedness, and dividend very much in line with the long-term financial targets. With that, back to you, Per. Thank you, Sven. Some final words from my side, starting with the outlook and starting with ICA Sweden. The first bullet here is only to remind everybody that the online implementation and the fact that we're going to have double cost during this year and also partly next year gives us a negative margin impact, and we stick to the estimate that we presented at the Capital Markets Day of 0.1% for 2021. We will also in the fourth quarter, as I talked about before, start the ramp-up of our new Ocado CFC and do some test runs, and of course, we're going to have some double costs coming out of that. We will have strong focus on price value. Very important, and the most important part of that is the push that we will do for our private label business. We will launch 8-12 new stores during this year. On the Baltic side, we have all seen the great numbers now for the second quarter. We will of course have a negative impact from the Lidl entry. We are still not sure exactly when they will launch in the Baltic, but the best estimate we have is that late September or early October, they will launch in Latvia and probably in the beginning of next year when it comes to Estonia. We will continue to focus and build capacity when it comes to e-commerce, and we will continue to launch new physical stores as well. This year it's some 22-25 new stores and roughly half of these stores in Lithuania. On the pharmacy side, we had a nice rebound as you saw, or a normalization in the second quarter. We will continue to focus on cost efficiency, and we had good improvements coming from that program already in the second quarter, and we will continue to work with that as we move forward. We will also now start to prepare for the new e-commerce warehouse, and we plan the move for mid-2022. This will give us better opportunities when it comes also to building a true omni-channel business. This year we will have some six to eight new pharmacies. On the real estate side, very important for us is of course to continue to push for new locations in metropolitan areas, as well as finalizing all of our key logistic project, especially on the online side, but also in other areas. On the banking part, we believe that our underlying income streams will gradually improve, linked to a better COVID-19 situation. We are also maintaining our guidance when it comes to the FOREX acquisition. The net effect of the FOREX acquisition will be some minus SEK 20 million for 2021. We are in the midst of setting up now the new mortgage joint venture, and the plan is that we should be able to start end of this year. When you look at the cost guidance and the CapEx guidance, it remains the same as we have talked about earlier, with SEK 3.5 million in investment and SEK 450 million in group cost. To sum it up, this is yet another stable or good quarter from ICA Gruppen. We have strong performance this quarter, especially so for Rimi Baltic and a nice rebound for our pharmacy business. For ICA Sweden, it's a stable quarter, of course affected by online investments. With that, Frans, back to you and hopefully some interesting questions. Thank you, Per. Indeed, please note that you can pose questions through our website. That is actually where the first question comes from. It's Xavier Lemaire from Bank of America. I guess this is a question that many of you ponder about, and that is: Can you please elaborate on the EBIT decline for ICA Sweden? How much is due to incremental costs for online? How much is linked to price effects? What should we expect in Q3 and Q4? I guess that's something for you, Sven. Yeah. No, thank you for that. Of course, I think above all, I would like to come back to what Per said when he presented the outlook here. Our best estimate is still in line with what we said at the Capital Markets Day. We will be approximately 0.1% down during the full year. It is, I think as many of you understand, very difficult to say exactly what the timing of that difference will be. I've spoken about that many times before. We cannot say exactly quarter by quarter how those variances will develop. We cannot take it as a given that it will be 0.1% every quarter. You will see from the report that we are talking about the negative Easter impact in this quarter. Also, clearly the effect of this positive one-off that we had last year. Concerning the price effect, it's much more complicated. You will see, looking back at the second quarter report of last year, you saw we reported very positive price growth at that time, and now we have the deflation. What exactly the impact of that is on results? Theoretically, you could say it should be very low, but we know from experience that price inflation, that is benefiting our business. All evidence suggests that. Exactly how much is very difficult to say. Now going forward, I think what we expect is that maybe still here a bit into the third quarter, there will be still sort of weak price effects. Over time, price inflation will come back. Again, very difficult to say exactly what will the timing of that be and how will that sort of offset the negative online effects that we will have. I could also mention that if you look at the second quarter of last year, you see that we talked about very good logistic efficiency at that time. I think at that time, when we had very strong volume development, it's sometimes the fact that you can get very good efficiency because the costs do not follow the very strong, quick sales uplift. Gradually over time, as you adjust your business to your operations to be able to cope with those higher volumes, you add a bit of cost. I will not say that we have bad efficiency in this second quarter, but we had very good efficiency in the second quarter of last year, as we wrote about at that time. There will be some fluctuations from quarter to quarter. I cannot say exactly how will this now look for the third quarter or the fourth quarter or so. I would say that as we have already, of course, some effects now as we have double cost, as Per talked about. We will come into a more intense phase towards the end of the year and so on, as we are then really implementing the new CFC and so on. If I should build a little bit on what you said, Sven, on the inflation side, I think it's absolutely right that we will still see low numbers also in the third quarter. We know that many prices are moving up, and if you look at the HUI estimate for the second half, they are talking about around 2%. We will see how it plays out, but we will definitely see inflation coming back into our system. Thank you. There are no further questions through the web, so please operator, go ahead. I hand over to you. Thank you. Just as a reminder, if you do wish to ask a question, please press 01 on your telephone keypad. Our first question is from Gustav Hagéus from SEB. Please go ahead. Thanks, operator. Good morning, guys. There was a comment that I found interesting that you mentioned that there was a margin improvement for the stores that have converted to the Ocado OSP. Could you sort of give us a little bit more color on that? Firstly, does it relate to EBIT margin or gross margin? Does it relate to your margin or the store owner's margin or both? Does it include also fees to Ocado and depreciations of assets or investments in the e-com business? That'd be helpful. Thanks. What we are talking about here is, of course, improvement for the retailer's margin, gross margin, and the EBIT margin, I should say. What we know also from evidence is that the Ocado platform will help us to drive both the basket size and the margin. It's mainly then it's the margin for the retailer. We will not give any details here to the numbers. As you can see, it's still early days. I think it's also important to underline here, what we have launched now is what you call a minimum viable product. It's still a rather basic version. As we move forward and as we take more stores on board, we are improving the platform as we speak. Over time, we will see better and better numbers. There is, of course, no impact on us. No on the group at this stage. Of course, the reason why we're doing an investment is, of course, that the efficiency will be very different compared to what you can have in a sort of semi-manual warehouse, a dark store that we have today. Yeah. The margin impact was something that Anders Svensson talked about during the CMD in December as well, if you remember. Mm-hmm. Yeah. Okay. On the market shares in July, I appreciate that you gave some color on that and with an effort to quantify the impact on Coop. Yeah. Obviously very hard to quantify but I appreciate that. Interested in the online market, which still was a bit below the market, which was negative. Do you believe that this might be an effect that you're over-indexed to click and collect and sort of cannibalizing on your own online when physical returns to a greater extent than the market as whole? How do you explain this discrepancy going into July? You mean that we had a slightly lower growth than the market also in July? I think you have to go back to July. First of all, July it's a different month because it's vacation times, et cetera. It's a bit harder to interpret the numbers. Just to remind ourselves, I think last year in July, we grew 40% faster than the market. I think that's the number, 40%. Of course, we are meeting very challenging numbers here because we have to keep in mind that the ICA retailer were much faster than other retailers to start to work with online. I think we have challenging numbers here. We are not worried about the fact that we are slightly behind market growth in July, I must say that. Yeah. Okay. Sticking to online, you mentioned that you are sort of under-indexed online, which is problematic when online grows. Could you just give us a little bit color what you think your market share online is now? I think you referenced your offline market share to be around somewhere in the mid-30s. If I recall correctly. Yeah, 36% or something like that. We haven't been public on our market shares for online. I don't think we have ever mentioned a specific number. We have said it's around the 30s. Interestingly enough, Gustav, from July and onwards, you can actually look at the HUI published DVI index numbers where they actually mention the size of the market as well. I don't have the number in my. I think you're right around 30%. We are clearly still below our numbers for the stores. Right. We will see what happens going forward now. I think it is likely to assume that we are going to see lower growth in the coming months when it comes to online. Of course, from a total share perspective and very short term, that will help us. Yeah. Lastly, I think you previously had a chart illustrating a correlation between number of COVID-19 cases and your market share development. Now, if we see a scenario where the Delta variant starts to get a little bit more traction here towards the latter part of the year again, would you then expect market shares to retreat again, or do you think that you're now rebased your shares and you can keep up with them? We actually see the same kind of pattern also in the second quarter. We didn't show a chart on that this time because we felt we have talked about it so much and the COVID-19 impact is less important, especially in the latter part of the quarter. We still see the same pattern. When we have more COVID-19 and more people in hospitals, we suffer from a share perspective. If there will be a large Delta impact, but it's very hard to predict that, but if there will be a large Delta impact, marginally we will suffer from that. Let's see, Gustav. I'm not an expert in predicting COVID-19. Neither am I Per. Thank you for taking my questions and good luck now. Yeah. Our next question is from Daniel Schmidt from Danske Bank. Please go ahead. Yes, good morning, Per, Sven and Frans. A couple of questions. Continuing on ICA Sweden to start with and this intense phase of transformation that you talked about, Per, and we all know that you have extra costs for online for 2021 and also start of 2022. Can you say anything more specific when it comes to the double warehouse capacity that you probably have then at the start of 2022, given that you're starting up Brunna and you still have your current dark store in place. When will that be dismantled and when will we start to see the real benefits from more efficient picking and packing in your numbers? I think the numbers we have here are the numbers that we have already disclosed. We are talking about this 0.1 impact for ICA Sweden on margin for 2021 and also a further 0.1 impact when it comes to 2022. That is related to exactly what you are talking about, double cost for running several warehouses, having the old platform and the new platform, the new Ocado platform at the same time. I think it's hard for us to be more specific on that. Also exactly when we will start to focus more on the CFC and less on the other warehouses. We will have to come back on that. It also, I think, depends very much, of course, Daniel, how the online growth will develop now over the coming 12 months, of course. I think the truth is we are not absolutely certain about when will we scale up and scale down and so on. That depends very much on the development. Daniel, I understand, of course, these are very relevant questions, but we have looked at the performance of this quarter. We have looked ahead also what we see now coming up. We have concluded that our best estimate is still this, what Per said. It is approximately 0.1 this year and another 0.1 next year for ICA Sweden. That is still the best estimate that we can give. Yeah. All right. No timing on when you shift completely and migrate to Brunna then. Are you preparing to be even more flexible when it comes to manning as you're soon running two warehouses in the greater Stockholm area? Of course, we are taking those kinds of factors into account when we are building our plans for the future. I think this is potentially a good subject to come back to when we have our Capital Markets Day in December. It's too early days. Yeah. All right. Moving on to the pharmacy business, and you're talking about a normalization, and of course, the market was up now by 7%, and you beat the market, and you clearly saw traffic coming back into the physical pharmacies. Is it reasonable to assume, given the easing of restrictions, that that has continued so far into the second half of this year? Also, with a new business head, area head in place since the beginning of May, what actions should we expect within the pharmacy business? You talk about six to eight new pharmacies. What do you think is going to be the net figure looking into the second half of this year and 2022? If we start there. Yeah. Yeah, you start, Sven. Yeah, Daniel, you will remember as I also touched briefly upon, we talked about all these measures because of course when we were in the first quarter, we did not know exactly what will happen going forward with restrictions and everything. There will inevitably be one day when we are coming out of the pandemic. I think that we are happy, as I said, about this rebound also margin-wise and so on. I think maybe also only important we touched upon that, of course, it has been a good summer. We need to take that into account. Mix effects are also quite positive in the pharmacy segment, traded goods and so on, sun lotions and all of that, good contributors. Now we're talking June, basically. Yeah. Yeah. That clearly had an impact also in the second quarter. To the extent that we believe that that continues in the third quarter, there will be a positive impact also from that. That may have had an impact of that. For the rest, we are also happy about the efficiency improvement, the cost savings, and so on. We will do everything we can to continue to come back on margins in the pharmacy segment. We are not yet up to the 2019 levels in terms of margins in the pharmacy segment. I think we can say Per, so far we are very happy with the way it has developed in the second quarter with the new CEO and everything and so on. Yeah. We are confident, but of course, as you point out, it's very much depending on COVID-19. We had a challenge in autumn, we will see how COVID and Delta plays out in the third and especially the fourth quarter. Yeah. On the store base, any news on the store base? I think the net will be basically zero this year. That's what we have said. We will have these six to eight new openings, all related to all close to ICA stores, and then we will close some six to eight pharmacies as well. Yeah. All right. Okay. The third topic, looking at the Rimi business area. I know that you've said this now for a couple of quarters when it comes to adopting price points and being maybe a little bit more forward-leaning on price given the entry of Lidl in Latvia and Estonia, even though that has been postponed now for a couple of quarters. I guess we're getting to a point where they eventually are going to open, and I think you said end of Q3 for Latvia and maybe start of next year for Estonia. Do you believe that the level of price points that you have now in those markets are going to be sustained when Lidl opens, or does that need to be reviewed further? I think that is the ten thousand dollar- question, really. Yeah. We don't know because we know pretty well what Lidl will do. What we need to do and how we will respond is very much dependent also on how our other competitors will respond. It is difficult to say. When we have built our plans, we have, of course, looked at very much at the development that we saw in Lithuania. We have done, I think it's fair to say, much better preparation in front of the launch now in Latvia and Estonia based on the learnings that we have on Lithuania. I think it's fair to say it's going to be challenging once they launch because Lidl, it's a strong player. They are very price-focused. On the other hand, longer term, we are confident that we can maintain a very strong franchise in both Latvia and Estonia based on what we have seen in Lithuania. You know as well as I do that if you look at our market shares now in Lithuania, they are up to the level that we have before the launch of Lidl. Yeah. Is it fair to assume given the delay that we've had with the Lidl entry, that you've had even more time to prepare for this? I think it's two factors there. We have had more time. We are really well prepared, and I think that's fair to say. On the other hand, once they launch, they will now launch with a larger impact because what's happened is obviously that they will have more stores ready for the first launch. In Latvia, I think we estimate up to 20 stores, and in Estonia, it's probably more up to 10 stores or something in that neighborhood. Once they launch, the initial impact will be slightly bigger than if they had launched six months ago. I hear you. Okay, good. Thank you. Maybe only adding there also, Daniel, that you take with it that, of course, and I don't know, maybe you have already spotted that yourself, of course, if you, again, make the comparison to 2019 in the pharmacy segment, as I said, we are not quite yet up to the 2019 level in the pharmacy segment. If you look at Rimi Baltic, of course, the EBIT margin is fantastic, not only comparing to 2020 but also to 2019. It is important still for you to realize that we are in a bit of a sweet spot in the Baltics here as we're coming out of the period of restrictions. It's not that we haven't tried to adjust prices and so on to make sure that we have the right price positions. We are in a bit sweet spot margin wise. We cannot expect this to be a normal level. Whatever happens with the Lidl entry, it is an extremely high margin level that we have in the second quarter. I would just like to stress that. 5.2 is a good level. Yeah. Absolutely. Thanks. Our next question is from Fredrik Ivarsson from ABG. Please go ahead. Thank you very much. Good morning, all. Just want to come back to what you just said, Sven, regarding the sweet spot in the Baltics you're currently in. Can you elaborate on that and in terms of consumer behavior or in what sense are you in a sweet spot in the Baltics? Obviously, we see that margin is very strong. Absolutely, Fredrik. As I said, what we have seen is a period, of course, where gradually restrictions have been lifted. First of all, in these ready-made meals, at the second quarter of last year at the time of restriction, that business was basically dead. It's a very good margin contributor. Now it's back, and it seems to be really back big time with people. They have waited for this for a long time, demand has been very high in the second quarter. I would say higher than what we have expected, we get a very nice mix impact from that. Also non-food, I would like to mention because there we had a period here during the restrictions where the specialized non-food stores were not allowed to be open. We were also not allowed in our stores to sell the non-food assortment for that reason. They gradually opened up, and we were then allowed to sell that assortment in our stores, whereas the specialized stores were still closed. You will understand from that, of course, we had a completely fantastic demand for our non-food assortment. That has been very clear in the second quarter here. Also the margin impact is very good from that non-food assortment. Thanks. That helps. Follow up there on the non-food part, would you mind to remind us of the share of Rimi Baltic non-food sales? You have those numbers, Frans? Yeah, it's like 4%-5% of sales. Yeah. 4%-5%. Excellent. Thanks. Not 45% but 4%- 5%. 4%-5%. Yep. Got it. Roughly 5%. Got it. I have a question if I barge in here from the web as well. It is Andrew at Exane, and the question reads, "Back on inflation, can it be passed through smoothly to the consumers in all markets, including the Baltics?" The second part of the question or the second question is, "The introduction of the Ocado OSP was especially complex because of the price differences between stores." I do not know if we have ever said that, though, but that is the question. Can you talk about experience here, please? Yeah. The first question, can we pass on price inflation? I think the short answer is yes. We might have a transition period where we get the price increase, and it will take a little bit of time before it's transferred. Ultimately, we will transfer it, and it goes, of course, both ways. When you have a decrease of prices, we will also decrease prices. That's the first one. When it comes to the second question, we have, of course, as part of our partnership with Ocado, developed the platform so that it fits for the ICA system and for the ICA retailers. It's not the worldwide OSP platform that we take. It's an ICA adapted platform. That is part of the minimum viable product that we have now introduced in the market. I think that's what we can say. Anything more there, Frans? Yeah, that, of course, just stress the fact that each ICA retailers also with the Ocado platform will continue to manage their own prices. Yeah, sure. Yeah. All right. Operator, back to you. Thank you. Just as a final reminder, if you would like to ask a question, please press zero one on your telephone keypad now. There are currently no further audio questions. I will hand the word back to you. Thank you very much, and thank you all. That was all for us today. We'll be back in October, and then, of course, please note that we will arrange our CMD on December 14th. With that, thank you very much, and see you next time.